2269:HKG
WuXi Biologics (Cayman) Inc
HK$48,20
arrow_downward
-0,90%(-0,44) 1 HR
16 Okt, 16.08.14 GMT+8 · HKD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk 2269...
Pembukaan
HK$49,98
Tinggi
HK$50,85
Rendah
HK$45,82
Kapitalisasi pasar
198,43Â M
Volume rata-rata
30,42Â jt
Volume
55,18Â jt
Rasio P/E
34,48
Harga tinggi dalam 52 minggu terakhir
HK$58,00
Harga rendah dalam 52 minggu terakhir
HK$28,48
EPS
HK$1,40
Saham beredar
1,23Â M
Jumlah karyawan
15Â rb
Pembukaan
HK$49,98
Tinggi
HK$50,85
Rendah
HK$45,82
Kapitalisasi pasar
198,43Â M
Volume rata-rata
30,42Â jt
Volume
55,18Â jt
Rasio P/E
34,48
Harga tinggi dalam 52 minggu terakhir
HK$58,00
Harga rendah dalam 52 minggu terakhir
HK$28,48
EPS
HK$1,40
Saham beredar
1,23Â M
Jumlah karyawan
15Â rb
Artikel berita
Dari sumber web dan partner berita
Vietnam.vn
·
1 jam yang lalu
Indeks S&P 500 mengalami penurunan mingguan paling tajam sejak Juni 2026.
Pluang
·
25 menit yang lalu
Bitcoin bisa turun ke $10.000 jika S&P 500 jatu...
Investing.com Indonesia
·
11 jam yang lalu
Mengapa SPDR S&P 500 ETF Trust turun hari ini?
XTB.com
·
1 hari yang lalu
Dow Jones Naik 1%, Yield Treasury AS Turun ke 5,1%
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Tentang WuXi Biologics (Cayman) Inc